Rheumatology International

, Volume 29, Issue 12, pp 1529–1530

Early onset neutropenia after mycophenolate mofetil in systemic sclerosis

  • Giovanna Cuomo
  • Giuseppina Abignano
  • Gabriele Valentini
Letter to the Editors

References

  1. 1.
    Ciancio G, Miller J, Gonwa TA (2005) Review of major clinical trial with mycophenolate mofetil in renal transplantation. Transplantation 80 (2 Suppl):S191–S200. doi:10.1097/01.tp.0000187035.22298.ba PubMedCrossRefGoogle Scholar
  2. 2.
    Kobashigawa JA, Meiser BM (2005) Review of major clinical trials with mycophenolate mofetil in cardiac transplantation. Transplantation 80 (2 Suppl):S235–S243. doi:10.1097/01.tp.0000186383.22264.b3 PubMedCrossRefGoogle Scholar
  3. 3.
    Chan TM, Li FK, Tang CS et al (2000) Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med 343:1156–1162. doi:10.1056/NEJM200010193431604 PubMedCrossRefGoogle Scholar
  4. 4.
    Ginzler EM, Dooley MA, Aranow C et al (2005) Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 353:2219–2228. doi:10.1056/NEJMoa043731 PubMedCrossRefGoogle Scholar
  5. 5.
    Shimizu H, Takahashi M, Takeda S et al (2004) Mycophenolate mofetil prevents transplant ateriosclerosis by direct inhibition of vascular smooth muscle cell proliferation. Transplantation 77:1661–1667. doi:10.1097/01.TP.0000127592.13707.B6 PubMedCrossRefGoogle Scholar
  6. 6.
    Miljkovic DJ, Cvetkovic I (2003) STOSIC-GRUJICIC, TRAJKOVIC V: mycophenolate acid inhibits activation of inducible nitric oxide synthase in rodent fibroblasts. Clin Exp Immunol 132:239–246. doi:10.1046/j.1365-2249.2003.02140.x PubMedCrossRefGoogle Scholar
  7. 7.
    Liossis SN, Bounas A, Andonopoulos AP (2006) Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease. Rheumatology 45:1005–1008. doi:10.1093/rheumatology/kei211 PubMedCrossRefGoogle Scholar
  8. 8.
    Nihtyanova SI, Brough GM, Black CM, Denton CP (2007) Mycophenolate mofetil in diffuse cutaneous systemic sclerosis—a retrospective analysis. Rheumatology 46:442–445. doi:10.1093/rheumatology/kel244 PubMedCrossRefGoogle Scholar
  9. 9.
    Vanthuyne M, Blockmans D, Westhovens R et al (2007) A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis. Clin Exp Rheumatol 25:287–292PubMedGoogle Scholar
  10. 10.
    Nogueras F, Espinosa MD, Mansilia A et al (2005) Mycophenolate mofetil-induce neutropania in liver transplantation. Transplant Proc 37:1509–1511. doi:10.1016/j.transproceed.2005.02.038 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Giovanna Cuomo
    • 1
  • Giuseppina Abignano
    • 1
  • Gabriele Valentini
    • 1
  1. 1.Rheumatology UnitSecond University of NaplesNaplesItaly

Personalised recommendations